• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[Treatment with tissue plasminogen activator (tPA) in risk patients with fibrin reactions after cataract operations].

作者信息

Heiligenhaus A, Schilling H, Schilling M, Mellin K B

机构信息

Universitäts-Augenklinik, Essen.

出版信息

Ophthalmologe. 1996 Feb;93(1):49-53.

PMID:8867161
Abstract

The postoperative course after cataract surgery can be complicated by the formation of severe fibrinous membranes, especially in cases with previous goniotrepanation, after syn echiolysis, iridotomy or iris suturing, and in patients with diabetes or uveitis. This study retrospectively analyzes the efficacy of intraocular tissue plasminogen activator (tPA) for fibrinolysis in these conditions commonly considered as contraindications to tPA therapy. When antiinflammatory therapy was unsuccessful in lysing fibrinous membranes, 10 micrograms of tPA (Actilyse) was injected into the anterior chamber following the first postoperative day (n = 15). In addition, topical corticosteroids and cycloplegics were given postoperatively. Lysis of the fibrinous membranes was achieved in all patients. However, in three cases lysis was incomplete or recurred. Complications of intraocular tPA therapy consisted of mild hyphema (n = 1) and transient dysfunction of the corneal endothelial cells (n = 2). In conclusion, the results suggest intraocular low-dose tPA as an effective approach for the treatment of severe fibrinous membranes after cataract surgery even in high-risk patients.

摘要

相似文献

1
[Treatment with tissue plasminogen activator (tPA) in risk patients with fibrin reactions after cataract operations].
Ophthalmologe. 1996 Feb;93(1):49-53.
2
[Tissue plasminogen activator in treatment of fibrinous membranes after cataract surgery].[组织型纤溶酶原激活剂在白内障手术后纤维蛋白膜治疗中的应用]
Klin Oczna. 1996;98(6):423-5.
3
Topical tissue plasminogen activator appears ineffective for the clearance of intraocular fibrin.
Ophthalmic Surg Lasers. 1998 Jun;29(6):476-83.
4
Treatment of intracameral fibrinous membranes with tissue plasminogen activator.用组织纤溶酶原激活剂治疗前房内纤维蛋白膜。
Ophthalmic Surg Lasers Imaging. 2003 Nov-Dec;34(6):451-6.
5
[Risk factors, prevention and therapy of fibrin reactions after IOL implantation].
Klin Monbl Augenheilkd. 1995 Nov;207(5):287-91. doi: 10.1055/s-2008-1035380.
6
Tissue plasminogen activator for the treatment of postoperative intraocular fibrinous membranes following cataract surgery.组织型纤溶酶原激活剂用于治疗白内障手术后的眼内纤维蛋白膜。
Ger J Ophthalmol. 1995 Mar;4(2):75-9.
7
[Treatment of intraocular fibrinous membrane by anterior chamber injection of tissue plasminogen activator after IOL implantation].
Zhonghua Yan Ke Za Zhi. 1998 Jul;34(4):291-3.
8
Clinical use of recombinant plasminogen activator for intraocular fibrinolysis.重组纤溶酶原激活剂在眼内纤维蛋白溶解中的临床应用。
Ger J Ophthalmol. 1992;1(5):354-60.
9
Intracameral recombinant tissue plasminogen activator for the treatment of severe fibrin reaction in endophthalmitis.前房内注射重组组织型纤溶酶原激活剂治疗眼内炎严重纤维蛋白反应
Eye (Lond). 2009 Jan;23(1):101-7. doi: 10.1038/sj.eye.6702984. Epub 2007 Sep 28.
10
[Band-like keratopathy after treatment of postoperative fibrin reaction with tissue plasminogen activator].
Klin Monbl Augenheilkd. 1996 Jul;209(1):43-6. doi: 10.1055/s-2008-1035276.

引用本文的文献

1
Recombinant tissue plasminogen activator in cases with fibrin formation after cataract surgery: a prospective randomised multicentre study.白内障手术后纤维蛋白形成病例中重组组织型纤溶酶原激活剂的应用:一项前瞻性随机多中心研究。
Br J Ophthalmol. 1998 Jul;82(7):810-5. doi: 10.1136/bjo.82.7.810.